Gilmore Neil O'Neill

CIK 1742084 · CEO · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$828.2K

Companies

4

Total Filings

28

Lifetime Open-Market Net

-$1.00M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EDIT CEO 248,313 $2.50 $620.8K -$1.00M 15 2026-06-05
Unity Biotechnology, Inc. (UBX) Delisted Director $0.20 $0 5 2024-06-21
Aptinyx Inc. (APTX) Delisted Director $0.06 $0 2 2022-05-31
SRPT EVP, R&D & CMO 13,546 $15.31 $207.4K $0 6 2021-03-10

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-28 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) $0 EDGAR
2021-03-10 SRPT Mixed +14,476 -$45.6K EDGAR
2021-03-05 SRPT Grant (A) +15,000 $0 EDGAR
2020-12-14 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) $0 EDGAR
2020-02-28 SRPT Grant (A) +6,700 $0 EDGAR
2019-05-24 SRPT Mixed +7,370 -$552.4K EDGAR
2019-03-04 SRPT Grant (A) $0 EDGAR
2018-06-11 SRPT Grant (A) $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.